Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

More than 170 people were screened for a condition known as diabetic eye disease through a free programme offered across the ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could support medical professionals in detecting and accurately diagnosing the stage ...

According to Varma, African Americans have a high rate of visual impairment and are especially likely to develop open-angle ...

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

In recent times, the computer vision (CV) then Internet of Things (IoT) technologies have proven their worth across a range of applications, with a notable focus on healthcare. IoT-driven healthcare ...

Letter writers discuss Improving Seniors’ Timely Access to Care Act, attacks against President Trump, and five tenets of ...

Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

The trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...

Diabetic retinopathy is the leading cause of vision loss in working-age adults worldwide, yet under-resourced regions lack ophthalmologists. Current state-of-the-art deeplearning systems struggle at ...